Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rubidium-82 PET determination of renal blood flow in healthy volunteers
2016-004080-39Phase 2Completed
- Sponsor
- Medicinsk Forskningsafsnit, Regionshospitalet Holstebro
- Start
- Oct 2016
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of rubidium-82 chloride, sponsored by Medicinsk Forskningsafsnit, Regionshospitalet Holstebro. Primary endpoint: Renal blood flow. Started Oct 2016; status: completed.
02
Drugs
rubidium-82 chloride
Beyond the preview
Go deeper on 2016-004080-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004080-39.